PropertyValue
?:abstract
  • COVID-19 is an emerging viral infection of zoonotic origin that is closely related to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused an outbreak in 2003. Therefore, scientists named the new virus SARS-CoV-2. On March 11, 2020, The World Health Organization (WHO) recognized COVID-19 as a global pandemic. At present, three vaccines have been approved or are being considered for approval by national regulatory agencies to immunize against COVID-19. However, the vaccines do not yet remain widely available and no specific treatment against the virus is available. The pathogenesis and proliferation pathways of SARS-CoV-2 are still not well known. Thus, in this article, the saponin glycyrrhizin is discussed as a new potential therapeutic agent of natural origin (licorice root, Glycyrrhizaglabra) for the potential treatment of COVID-19 infections.
?:creator
?:doi
  • 10.2174/1389557521666210210160237
?:doi
?:journal
  • Mini_reviews_in_medicinal_chemistry
?:license
  • unk
?:pmid
?:pmid
  • 33568033
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19).
?:type
?:year
  • 2021-02-10

Metadata

Anon_0  
expand all